25Jul, 2025
Aberdeen’s Akus on the struggles facing healthcare, biotech investors
Jason Akus, Head of Healthcare Investing for Aberdeen Investments, says that current conditions for healthcare and biotech investing are making for "one of the most challenging, difficult and dislocated environments I've seen." While trades in technology, artificial intelligence and...
17Dec, 2020
Demand for CEFs Expected to Increase as Investors Look for Alternative Fixed Income Products
As traditional fixed-income portfolios and allocations are becoming a thing of the past, individual investors are starting looking at alternative fixed income solutions such as closed-end funds.
17Dec, 2020
Closed-End Funds Offer Equity Investment Opportunities Despite Increased Volatility
Although indiscriminate volatility has caused valuations to decline significantly since March, managers have been able to take advantage of lower prices to cheaply buy some company equities.


